Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
114 EUR | +0.13% | -.--% | -.--% |
05-07 | Dsm-Firmenich Ag Approves Retirement of Pradeep Pant from the Board | CI |
05-07 | Dsm-Firmenich Ag Approves the Dividend, Payable May 16, 2024 | CI |
Sales 2024 * | 12.64B 13.68B 18.71B | Sales 2025 * | 13.31B 14.41B 19.71B | Capitalization | 28.39B 30.74B 42.03B |
---|---|---|---|---|---|
Net income 2024 * | 452M 490M 669M | Net income 2025 * | 781M 846M 1.16B | EV / Sales 2024 * | 2.47 x |
Net Debt 2024 * | 2.86B 3.09B 4.23B | Net Debt 2025 * | 2.59B 2.81B 3.84B | EV / Sales 2025 * | 2.33 x |
P/E ratio 2024 * |
62.8
x | P/E ratio 2025 * |
36.3
x | Employees | 28,685 |
Yield 2024 * |
2.35% | Yield 2025 * |
2.31% | Free-Float | 25.03% |
Latest transcript on Koninklijke DSM
1 day | +0.13% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 89-12-31 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 23-08-31 |
Sarah Reisinger
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 23-01-31 | |
Thomas Leysen
CHM | Chairman | 63 | 23-01-31 |
Director/Board Member | 62 | 23-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.43% | 304 M€ | +16.72% | ||
1.13% | 17 M€ | +8.99% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.21% | 895B | |
0.00% | 239B | |
+26.15% | 176B | |
-2.96% | 133B | |
+45.67% | 88.64B | |
-5.02% | 74.24B | |
-5.65% | 57.07B | |
+37.77% | 37.69B | |
-32.34% | 35.66B |
- Stock Market
- Equities
- DSFIR Stock
- DSM Stock